Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for inhibiting CD32B expressing cells in IgG4-related diseases

Methods and compositions for inhibiting CD32B expressing cells in IgG4-related diseases

US Patent 12509518 · Granted Dec 30, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and apparatus to generate calibration models in a cloud environment2025
Heterodimeric antibodies that bind somatostatin receptor 22024
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2022
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2022
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2022
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2022
Heterodimeric antibodies that bind somatostatin receptor 22022
Heterodimeric antibodies that bind somatostatin receptor 22019
Therapeutic targets and molecules2012
Rapid ophthalmic disinfection solution using salt and glycol and/or lower alkano1998
Rapid ophthalmic disinfection method and solution using salt and glycol and/or l1995
Rapid method for cleaning/disinfecting ophthalmic devices using novel glycol/low1995